2022
DOI: 10.1002/jcph.1987
|View full text |Cite
|
Sign up to set email alerts
|

Predicted Cardiac Functional Responses to Renal Actions of SGLT2i in the DAPACARD Trial Population: A Mathematical Modeling Analysis

Abstract: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) have been shown to reduce the risk of worsening heart failure (HF) in subjects with HF and a reduced ejection fraction (HFrEF) in multiple clinical trials. The DAPACARD clinical trial was conducted to examine the effects of dapagliflozin on cardiac substrate uptake, myocardial efficiency, and myocardial contractile work in subjects with type 2 diabetes mellitus. As a complement to the clinical study, a mechanistic mathematical model of cardiorenal physiology … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 54 publications
0
0
0
Order By: Relevance
“…The effects of changes in preload and afterload on cardiac remodeling over time can then be simulated through growth and remodeling laws that link myocardial loading to changes in myocyte diameter/length, and subsequently to LV wall thickness and chamber volume [39]. The model has been validated by reproducing clinical trials in LV hypertrophy [39] and HFrEF patients [44][45][46].…”
Section: Introductionmentioning
confidence: 99%
“…The effects of changes in preload and afterload on cardiac remodeling over time can then be simulated through growth and remodeling laws that link myocardial loading to changes in myocyte diameter/length, and subsequently to LV wall thickness and chamber volume [39]. The model has been validated by reproducing clinical trials in LV hypertrophy [39] and HFrEF patients [44][45][46].…”
Section: Introductionmentioning
confidence: 99%